Stavzor and Dysphagia aggravated - a phase IV clinical study of FDA data
Summary:
Dysphagia aggravated is reported only by a few people who take Stavzor.
The phase IV clinical study analyzes which people take Stavzor and have Dysphagia aggravated. It is created by eHealthMe based on reports of 34 people who have side effects while taking Stavzor from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
34 people reported to have side effects when taking Stavzor.
Among them, 2 people (5.88%) have Dysphagia aggravated.
What is Stavzor?
Stavzor has active ingredients of valproic acid. eHealthMe is studying from 52 Stavzor users for its effectiveness, alternative drugs and more.
What is Dysphagia aggravated?
Dysphagia aggravated (serious condition in which swallowing is difficult or painful) is found to be associated with 1,564 drugs and 461 conditions by eHealthMe.
Number of Stavzor and Dysphagia aggravated reports submitted per year:
Time on Stavzor when people have Dysphagia aggravated *:
Gender of people who have Dysphagia aggravated when taking Stavzor*:
Age of people who have Dysphagia aggravated when taking Stavzor *:
Common drugs people take besides Stavzor *:
Common side effects people have besides Dysphagia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Stavzor and have Dysphagia aggravated?
Check whether Dysphagia aggravated is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
Related studies
How severe was Dysphagia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of valproic acid:
Alternative drugs to, pros and cons of Stavzor:
- Stavzor (52 reports)
Dysphagia aggravated treatments and more:
- Dysphagia aggravated (9 reports)
COVID vaccines that are related to Dysphagia aggravated:
- Dysphagia aggravated in Moderna COVID Vaccine
- Dysphagia aggravated in Pfizer BioNTech Covid Vaccine
- Dysphagia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Dysphagia aggravated:
- Aspirin: 4,818 reports
- Prednisone: 4,430 reports
- Omeprazole: 3,202 reports
- Lisinopril: 2,813 reports
- Nexium: 2,643 reports
- Synthroid: 2,587 reports
- Fosamax: 2,524 reports
- Gabapentin: 2,402 reports
- Lipitor: 2,354 reports
- Amlodipine: 2,344 reports
All the drugs that are associated with Dysphagia aggravated:
- Dysphagia aggravated (1,564 drugs)
Common conditions associated with Dysphagia aggravated:
- High blood pressure: 4,427 reports
- Multiple sclerosis: 3,600 reports
- Pain: 3,308 reports
- Depression: 2,699 reports
- Parkinson's disease: 2,677 reports
- Osteoporosis: 2,629 reports
- Rheumatoid arthritis: 2,605 reports
- High blood cholesterol: 2,152 reports
All the conditions that are associated with Dysphagia aggravated:
- Dysphagia aggravated (461 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on valproic acid (the active ingredients of Stavzor) and Stavzor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Revlimid and Kapidex drug interaction - 4 seconds ago
- How effective is Chlorpheniramine Maleate for Allergic Rhinitis? - 8 seconds ago
- Bipolar I Disorder and Dermatitis Medicamentosa - 9 seconds ago
- Back Pain and Amyotrophic Lateral Sclerosis - 16 seconds ago
- Depression and Major Depression - 17 seconds ago
- How effective is Sudafed for Allergic Rhinitis? - 18 seconds ago
- Trandate and Glucosamine drug interaction - 19 seconds ago
- Back Pain and Agranulocytosis - 20 seconds ago
- Chills and Agitation - 22 seconds ago
- Chlamydial Cervicitis and Pulmonary Artery Stenosis - 23 seconds ago